All stock reports

RPPL evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-09-29T14:01:25.667923+00:00

Metrics

latest_annual_period
2026-03-31
revenue
3321839000.0
net_income
172525000.0
operating_cash_flow
101055000.0
free_cash_flow
-20539000.0
total_assets
3496465000.0
total_liabilities
1615105000.0
total_equity
1880545000.0
cash
50389000.0
total_debt
1234491000.0
revenue_growth
0.013417912984001523
earnings_growth
1.1671272453209394
net_margin
0.05193659295348149
roe
0.09174202159480363
debt_to_equity
0.6564538471560106
cash_conversion
0.5857411969279814
free_cash_flow_margin
-0.006183020911007427
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
Not supplied
dividend_yield
Not supplied

Other positional research

Evidence unavailable

1 opportunity assessments; compare evidence and conditions below.

Price Dislocation

Evidence unavailable. Direction: LONG.

Flags large price dislocations for research without asserting unsupported fundamental quality

  • Candidate data quality and liquidity must both pass.
Eligible expression
None selected
Expression comparison
No eligible instrument selected.
Invalidation
Continued price deterioration or adverse fundamental evidence
Entry rule
Not supplied
Entry range (INR)
Not supplied
Exit / review rule
Not supplied
Planned exit
Not supplied
Plan valid until
Not supplied
Promotion reference
Not supplied
Instrument scenarios in INR; quantities are illustrative, not personal sizing
InstrumentEvidence statusContractQuantityCapital / marginTarget P&L after costsStop-level scenario P&LStress lossConditions and limitations
Decision provenance and limitations
Decision ID
decision-edc323b33592232f252b8253e4f1d40b3f391a9ffcb90bae1924546b299ec3b3
Policy
stock-decisions-v1
Evidence bundle hash
f61428ae4d2a147529ecdea08d1543994f22b964f8e6e7b4b203e37538b947ae
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: ecf4f2565124810edeac4ebccdb3cbd8afd2a6b1398ab9ba2e6afc8f36b5cd08
  • daily-price: ed44d1184b989ee7863aa3a9e7cef76413cb6975910eb81dd56a34edc3d326b8
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Numerical report available. Evidence briefing is queued or awaiting retry.

Cached observations and evidence limits